N6-Isopentenyladenosine: A potential therapeutic agent for a variety of epithelial cancers

International Journal of Cancer

Volumn 120, Issue 12, 2007, Pages 2744-2748

  Spinola, Monica ^a   Colombo, Francesca ^a   Falvella, F Stefania ^a   Dragani, Tommaso A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cancer cell lines; FDPS; Therapy; TRIT1

Indexed keywords

6 N (3,3 DIMETHYLALLYL)ADENOSINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOMA; CELL PROLIFERATION; CELL TYPE; CLONOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GERANYLTRANSTRANSFERASE; HT29 CELLS; HUMANS; ISOPENTENYLADENOSINE; NEOPLASMS; TIME FACTORS; TUMOR STEM CELL ASSAY;

EID: 34247498184     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22601     Document Type: Article

References (16)

1. Takei K, Sakakibara H, Sugiyama T. Identification of genes encoding adenylate isopentenyltransferase, a cytokinin biosynthesis enzyme, in Arabidopsis thaliana. J Biol Chem 2001;276:26405-10.
2. Spinola M, Pedotti P, Dragani TA, Taioli E. Meta-analysis suggests association of L-myc EcoRI polymorphism with cancer prognosis. Clin Cancer Res 2004;10:4769-75.
3. Spinola M, Galvan A, Pignatiello C, Conti B, Pastorino U, Nicander B, Paroni R, Dragani TA. Identification and functional characterization of the candidate tumor suppressor gene TRIT1 in human lung cancer. Oncogene 2005;24:5502-09.
4. Haberer G, Kieber JJ. Cytokinins. New insights into a classic phytohormone. Plant Physiol 2002;128:354-62.
5. Golovko A, Hjalm G, Sitbon F. Nicander B. Cloning of a human tRNA isopentenyl transferase. Gene 2000;258:85-93.
6. Persson BC, Esberg B, Olafsson O, Bjork GR. Synthesis and function of isopentenyl adenosine derivatives in tRNA. Biochimie 1994;76:1152-60.
7. Laten HM, Zahareas-Doktor S. Presence and source of free isopentenyladenosine in yeasts. Proc Natl Acad Sci USA 1985;82:1113-15.
8. Burns DM, Rodi CP, Agris PF. Natural occurrence of an inhibitor of mammalian cell growth in human and mouse cells of normal and tumor origin. Cancer Biochem Biophys 1976;1:269-80.
9. Vold BS, Keith DE, Jr, Slavik M. Urine levels of N-[9-(β- D-ribofuranosyl)purin-6-ylcarbamoyl]-L-threonine, N6-(delta 2-isopentenyl)adenosine, and 2′-O-methylguanosine as determined by radioimmunoassay for normal subjects and cancer patients. Cancer Res 1982;42:5265-69.
10. Ishii Y, Hori Y, Sakai S, Honma Y. Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentiation-inducing hormones. Cell Growth Differ 2002;13:19-26.
11. Laezza C, Notarnicola M, Caruso MG, Messa C, Macchia M, Bertini S, Minutolo F, Portella G, Fiorentino L, Stingo S, Bifulco M. N6- isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation. FASEB J 2006;20:412-18.
12. Chang Y, Hacker B. Antineoplastic effects of N6-(delta 2-isopentenyl)adenosine against L-1210 mouse lymphocytic leukemic cells using a polymeric delivery system. J Pharm Sci 1982;71:328-31.
13. Divekar AY, Slocum HK, Hakala MT. N6-(delta2-isopentenyl)adenosine 5′-monophosphate: formation and effect on purine metabolism in cellular and enzymatic systems. Mol Pharmacol 1974;10:529-43.
14. Slocum HK, Hakala MT. Mechanism of natural resistance to N6-(delta2-isopentenyl)adenosine in cultured cells. Cancer Res 1975;35:423-28.
15. Suk D, Simpson CL, Mihich E. Toxicological and antiproliferative effects of N6-(delta2-isopentenyl) adenosine, a natural component of mammalian transfer RNA. Cancer Res 1970;30:1429-36.
16. Moyer JD, Malinowski N, Ayers O. Salvage of circulating pyrimidine nucleosides by tissues of the mouse. J Biol Chem 1985:260:2812-18.